SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

The FDA issued a Complete Response Letter for Summits ivonescimab application in post-TKI EGFR-mutated lung cancer, saying the evidence did not establish a statistically significant overall-survival benefit; traders are reacting to the setback and debating whether it undermines the broader drug thesis. Bearish voices see a major regulatory blow, while bullish traders argue the decision is limited to this indication and are focused on future trials, especially HARMONi-3.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharmas Phase 3 APPROACH topline readout for HLP003 in major depressive disorder is the dominant focus, with traders treating the results as a high-stakes catalyst. Bullish investors cite the adjunctive design and potential for shorter clinic sessions, while others are wary of disappointing data and dilution; unverified claims about the results remain speculation.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Positive interim results from Alpha Taus REGAIN trial in recurrent glioblastoma are driving attention: all treated patients were reported alive, with objective responses in the six evaluable patients. Traders are enthusiastic about the early signal and its potential implications, while some stress that the small cohort needs longer follow-up to clarify durability and safety.

Terra Classic (LUNC) is a cryptocurrency launched in 2019. Terra Classic has a current supply of 6,443,322,322,905.82878 with 5,522,160,998,025.532096 in circulation. The last known price of Terra Classic is 0.00003358 USD and is down -9.02 over the last 24 hours. It is currently trading on 557 active market(s) with $10,293,777.48 traded over the last 24 hours. More information can be found at https://www.terra-classic.io.

Terra Luna Classic

A sharp LUNC move and reported pickup in trading volume have renewed attention, with traders pointing to token burns, the anticipated Market Module 2.0 rollout, and speculation that litigation could lead to a large supply reduction. Bulls see these as potential catalysts, while skeptics argue that the huge supply and weak activity limit the impact of burns.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Speculation that Nvidia CEO Jensen Huang could return is driving hopes for a broader tech-led rebound, with traders also watching Nvidia earnings and the Anthropic IPO. Others doubt the comeback rumor and point to market weakness, macro risks, and volatility as reasons for caution.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Traders are debating whether enterprise AI will create implementation work for Accenture or weaken its traditional consulting model, with concerns that clients are pausing projects when returns are unclear and leaving consultants underused. Some see the AI-disruption fears as overdone and point to valuation as support, but the discussion is dominated by uncertainty over client demand and billable work.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is moving amid volatile natural-gas trading, with traders pointing to warm-weather expectations, ample storage and strong production as bearish pressures on gas prices. Some see KOLDs strength as a response to that bearish setup, while others warn that forecast cold snaps and crowded short positions could trigger a natural-gas squeeze and reverse the move.

Modine Manufacturing Co. engages in the provision of thermal management products and solutions. It operates through the Climate Solutions and Performance Technologies business segments. The Climate Solutions segment provides climate-controlled solutions and components, heat transfer products, heating, ventilating, air conditioning and refrigeration products, and data center cooling solutions. The Performance Technologies segment designs and manufactures air- and liquid-cooled technology for vehicular, stationary power, and industrial applications. In addition, the Performance Technologies segment provides thermal solutions to zero-emission and hybrid commercial vehicle and automotive customers, and coating products and application services. The company was founded by Arthur B. Modine on June 23, 1916 and is headquartered in Racine, WI.

Modine Manufacturing Co.

A report that Samsung is in talks to acquire Modine has driven a sharp share-price surge, but no deal or terms have been confirmed. Traders are divided over whether the takeover speculation justifies further gains or whether the stock could retreat, with some also citing margin pressure and cash use in Modines data-center expansion.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 0.92173784 USD and is down -8.73 over the last 24 hours. It is currently trading on 1896 active market(s) with $4,059,642,828.82 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep drop below the psychologically important $1 level amid a broader crypto selloff is dominating discussion, with traders pointing to Bitcoin weakness and liquidations. The community is split between calling the move capitulation and buying the dip, and expecting further losses amid concerns about weak momentum and limited catalysts.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is drawing attention after quarterly results topped estimates and the company raised its full-year revenue outlook, while traders focus on oncology progressespecially pumitamigas it shifts beyond COVID vaccines. Bulls see promise in the pipeline, while skeptics question clinical execution and compare its progress unfavorably with Moderna.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
